Structure

Physi-Chem Properties

Molecular Weight:  434.25
Volume:  466.767
LogP:  4.615
LogD:  3.609
LogS:  -4.559
# Rotatable Bonds:  1
TPSA:  74.6
# H-Bond Aceptor:  4
# H-Bond Donor:  2
# Rings:  5
# Heavy Atoms:  4

MedChem Properties

QED Drug-Likeness Score:  0.322
Synthetic Accessibility Score:  5.356
Fsp3:  0.571
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Accepted
Chelating Alert:  1
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.896
MDCK Permeability:  2.4004986698855646e-05
Pgp-inhibitor:  0.075
Pgp-substrate:  0.007
Human Intestinal Absorption (HIA):  0.009
20% Bioavailability (F20%):  0.003
30% Bioavailability (F30%):  0.028

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.456
Plasma Protein Binding (PPB):  99.36675262451172%
Volume Distribution (VD):  1.583
Pgp-substrate:  1.8782532215118408%

ADMET: Metabolism

CYP1A2-inhibitor:  0.042
CYP1A2-substrate:  0.755
CYP2C19-inhibitor:  0.068
CYP2C19-substrate:  0.714
CYP2C9-inhibitor:  0.284
CYP2C9-substrate:  0.281
CYP2D6-inhibitor:  0.267
CYP2D6-substrate:  0.099
CYP3A4-inhibitor:  0.89
CYP3A4-substrate:  0.871

ADMET: Excretion

Clearance (CL):  15.29
Half-life (T1/2):  0.247

ADMET: Toxicity

hERG Blockers:  0.065
Human Hepatotoxicity (H-HT):  0.224
Drug-inuced Liver Injury (DILI):  0.077
AMES Toxicity:  0.198
Rat Oral Acute Toxicity:  0.773
Maximum Recommended Daily Dose:  0.953
Skin Sensitization:  0.178
Carcinogencity:  0.881
Eye Corrosion:  0.004
Eye Irritation:  0.19
Respiratory Toxicity:  0.958

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC199936

Natural Product ID:  NPC199936
Common Name*:   23-Oxo-Isotingenone
IUPAC Name:   (6aS,6aS,6bS,8aS,11R,12aR)-2,3-dihydroxy-6a,6a,6b,8a,11-pentamethyl-10-oxo-8,9,11,12,12a,13-hexahydro-7H-picene-4-carbaldehyde
Synonyms:   23-Oxo-Isotingenone
Standard InCHIKey:  ZIHMKXOMCSCWJB-AHRBEJICSA-N
Standard InCHI:  InChI=1S/C28H34O4/c1-16-12-23-25(2,14-22(16)31)10-11-28(5)26(3)8-6-17-18(20(26)7-9-27(23,28)4)13-21(30)24(32)19(17)15-29/h6-8,13,15-16,23,30,32H,9-12,14H2,1-5H3/t16-,23-,25+,26-,27+,28-/m1/s1
SMILES:  C[C@@H]1C[C@@H]2[C@@](C)(CC[C@]3(C)[C@]4(C)C=Cc5c(cc(c(c5C=O)O)O)C4=CC[C@@]23C)CC1=O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL454829
PubChem CID:   10788966
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0002448] Benzenoids
      • [CHEMONTID:0000025] Phenanthrenes and derivatives

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO13212 Maytenus amazonica Species Celastraceae Eukaryota n.a. n.a. n.a. PMID[10096852]
NPO13212 Maytenus amazonica Species Celastraceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT168 Cell Line P388 Mus musculus IC50 = 10.0 ug.mL-1 PMID[451880]
NPT41 Individual Protein Aldose reductase Homo sapiens IC50 = 25.0 ug.mL-1 PMID[451880]
NPT81 Cell Line A549 Homo sapiens IC50 = 10.0 ug.mL-1 PMID[451880]
NPT139 Cell Line HT-29 Homo sapiens IC50 = 10.0 ug.mL-1 PMID[451880]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 10.0 ug.mL-1 PMID[451880]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC199936 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9137 High Similarity NPC277559
0.911 High Similarity NPC470037
0.9 High Similarity NPC49911
0.8951 High Similarity NPC184935
0.8904 High Similarity NPC10842
0.8897 High Similarity NPC470038
0.8803 High Similarity NPC206207
0.8707 High Similarity NPC476535
0.8681 High Similarity NPC476534
0.8671 High Similarity NPC141368
0.8662 High Similarity NPC7464
0.8639 High Similarity NPC68441
0.8592 High Similarity NPC103082
0.8592 High Similarity NPC153088
0.8582 High Similarity NPC138472
0.8582 High Similarity NPC111845
0.8582 High Similarity NPC476282
0.8571 High Similarity NPC243305
0.8571 High Similarity NPC291001
0.8562 High Similarity NPC471972
0.8562 High Similarity NPC30846
0.8562 High Similarity NPC469855
0.8562 High Similarity NPC471971
0.8552 High Similarity NPC470035
0.8552 High Similarity NPC471853
0.8542 High Similarity NPC289358
0.8542 High Similarity NPC42384
0.8542 High Similarity NPC28592
0.8542 High Similarity NPC114333
0.8542 High Similarity NPC5014
0.8542 High Similarity NPC297797
0.8542 High Similarity NPC473779
0.8542 High Similarity NPC245760
0.8542 High Similarity NPC149773
0.8542 High Similarity NPC23667
0.8542 High Similarity NPC91887
0.8542 High Similarity NPC50615
0.8542 High Similarity NPC473479
0.8542 High Similarity NPC477849
0.8542 High Similarity NPC469857
0.8542 High Similarity NPC165191
0.8542 High Similarity NPC51531
0.8542 High Similarity NPC157284
0.8542 High Similarity NPC46242
0.8483 Intermediate Similarity NPC294330
0.8478 Intermediate Similarity NPC71610
0.8477 Intermediate Similarity NPC476532
0.8477 Intermediate Similarity NPC474191
0.8462 Intermediate Similarity NPC258502
0.8451 Intermediate Similarity NPC294226
0.8446 Intermediate Similarity NPC469854
0.8446 Intermediate Similarity NPC469856
0.844 Intermediate Similarity NPC244699
0.8435 Intermediate Similarity NPC248068
0.8429 Intermediate Similarity NPC474546
0.8425 Intermediate Similarity NPC473527
0.8417 Intermediate Similarity NPC471530
0.8414 Intermediate Similarity NPC230811
0.8414 Intermediate Similarity NPC471974
0.8414 Intermediate Similarity NPC469681
0.8414 Intermediate Similarity NPC61398
0.8414 Intermediate Similarity NPC416
0.8414 Intermediate Similarity NPC469680
0.8397 Intermediate Similarity NPC185617
0.8394 Intermediate Similarity NPC198014
0.8382 Intermediate Similarity NPC253627
0.8369 Intermediate Similarity NPC117609
0.8366 Intermediate Similarity NPC476533
0.8345 Intermediate Similarity NPC471152
0.8344 Intermediate Similarity NPC46549
0.8344 Intermediate Similarity NPC264229
0.8333 Intermediate Similarity NPC471970
0.8333 Intermediate Similarity NPC43353
0.8333 Intermediate Similarity NPC283088
0.8333 Intermediate Similarity NPC273798
0.8322 Intermediate Similarity NPC145301
0.8322 Intermediate Similarity NPC469375
0.8322 Intermediate Similarity NPC144247
0.8322 Intermediate Similarity NPC8493
0.8322 Intermediate Similarity NPC477139
0.8322 Intermediate Similarity NPC53896
0.8322 Intermediate Similarity NPC4170
0.8322 Intermediate Similarity NPC294679
0.8311 Intermediate Similarity NPC477209
0.831 Intermediate Similarity NPC85342
0.8301 Intermediate Similarity NPC144283
0.8298 Intermediate Similarity NPC146647
0.8298 Intermediate Similarity NPC34414
0.8264 Intermediate Similarity NPC50924
0.8264 Intermediate Similarity NPC202225
0.8252 Intermediate Similarity NPC58685
0.8227 Intermediate Similarity NPC3009
0.8227 Intermediate Similarity NPC48248
0.8224 Intermediate Similarity NPC132810
0.8219 Intermediate Similarity NPC147418
0.8212 Intermediate Similarity NPC143685
0.8188 Intermediate Similarity NPC477873
0.8188 Intermediate Similarity NPC11250
0.8188 Intermediate Similarity NPC85310
0.8188 Intermediate Similarity NPC469447
0.8188 Intermediate Similarity NPC469520
0.8182 Intermediate Similarity NPC471851
0.8182 Intermediate Similarity NPC70320
0.8169 Intermediate Similarity NPC276238
0.8169 Intermediate Similarity NPC99731
0.8156 Intermediate Similarity NPC72667
0.8156 Intermediate Similarity NPC78364
0.8156 Intermediate Similarity NPC473787
0.8156 Intermediate Similarity NPC176130
0.8156 Intermediate Similarity NPC69424
0.8156 Intermediate Similarity NPC84672
0.8151 Intermediate Similarity NPC193358
0.8146 Intermediate Similarity NPC75295
0.8146 Intermediate Similarity NPC258856
0.8143 Intermediate Similarity NPC137750
0.8143 Intermediate Similarity NPC87985
0.8138 Intermediate Similarity NPC161964
0.8138 Intermediate Similarity NPC287604
0.8138 Intermediate Similarity NPC472262
0.8129 Intermediate Similarity NPC3744
0.8129 Intermediate Similarity NPC137125
0.8129 Intermediate Similarity NPC164912
0.8121 Intermediate Similarity NPC92079
0.8117 Intermediate Similarity NPC48949
0.8116 Intermediate Similarity NPC154696
0.8112 Intermediate Similarity NPC108129
0.8112 Intermediate Similarity NPC55949
0.8099 Intermediate Similarity NPC234175
0.8095 Intermediate Similarity NPC475957
0.8095 Intermediate Similarity NPC305060
0.8095 Intermediate Similarity NPC53001
0.8092 Intermediate Similarity NPC39361
0.8092 Intermediate Similarity NPC63918
0.8089 Intermediate Similarity NPC279605
0.8085 Intermediate Similarity NPC3224
0.8085 Intermediate Similarity NPC295202
0.8085 Intermediate Similarity NPC254492
0.8085 Intermediate Similarity NPC136342
0.8085 Intermediate Similarity NPC49647
0.8085 Intermediate Similarity NPC227741
0.8079 Intermediate Similarity NPC309169
0.8079 Intermediate Similarity NPC196941
0.8079 Intermediate Similarity NPC53520
0.8079 Intermediate Similarity NPC79627
0.8071 Intermediate Similarity NPC234890
0.8071 Intermediate Similarity NPC199273
0.8071 Intermediate Similarity NPC15127
0.8071 Intermediate Similarity NPC181334
0.8071 Intermediate Similarity NPC74507
0.8069 Intermediate Similarity NPC115458
0.8069 Intermediate Similarity NPC78307
0.8069 Intermediate Similarity NPC314048
0.8069 Intermediate Similarity NPC52407
0.8067 Intermediate Similarity NPC11314
0.8065 Intermediate Similarity NPC35
0.8065 Intermediate Similarity NPC118427
0.8065 Intermediate Similarity NPC75377
0.8056 Intermediate Similarity NPC72669
0.8056 Intermediate Similarity NPC41847
0.8056 Intermediate Similarity NPC17083
0.8056 Intermediate Similarity NPC474517
0.8054 Intermediate Similarity NPC203063
0.8052 Intermediate Similarity NPC237441
0.8052 Intermediate Similarity NPC142654
0.805 Intermediate Similarity NPC141574
0.8043 Intermediate Similarity NPC32322
0.8043 Intermediate Similarity NPC259703
0.8042 Intermediate Similarity NPC303910
0.8042 Intermediate Similarity NPC25736
0.8042 Intermediate Similarity NPC171460
0.8041 Intermediate Similarity NPC87723
0.8039 Intermediate Similarity NPC476821
0.8039 Intermediate Similarity NPC52692
0.8027 Intermediate Similarity NPC472308
0.8027 Intermediate Similarity NPC315275
0.8027 Intermediate Similarity NPC86524
0.8026 Intermediate Similarity NPC73416
0.8026 Intermediate Similarity NPC160777
0.8015 Intermediate Similarity NPC16030
0.8014 Intermediate Similarity NPC293454
0.8014 Intermediate Similarity NPC131799
0.8 Intermediate Similarity NPC91019
0.8 Intermediate Similarity NPC472904
0.8 Intermediate Similarity NPC471187
0.8 Intermediate Similarity NPC375356
0.8 Intermediate Similarity NPC187843
0.8 Intermediate Similarity NPC106519
0.8 Intermediate Similarity NPC280295
0.7987 Intermediate Similarity NPC472903
0.7986 Intermediate Similarity NPC136588
0.7986 Intermediate Similarity NPC199253
0.7974 Intermediate Similarity NPC477208
0.7973 Intermediate Similarity NPC290030
0.7972 Intermediate Similarity NPC282923
0.7972 Intermediate Similarity NPC96024
0.7962 Intermediate Similarity NPC474000
0.7962 Intermediate Similarity NPC305710
0.7962 Intermediate Similarity NPC475770
0.7961 Intermediate Similarity NPC477913
0.7961 Intermediate Similarity NPC300603

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC199936 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8639 High Similarity NPD7422 Clinical (unspecified phase)
0.8243 Intermediate Similarity NPD8166 Discontinued
0.7887 Intermediate Similarity NPD1470 Approved
0.7857 Intermediate Similarity NPD1201 Approved
0.7778 Intermediate Similarity NPD3300 Phase 2
0.7714 Intermediate Similarity NPD3019 Approved
0.7714 Intermediate Similarity NPD2932 Approved
0.7667 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7635 Intermediate Similarity NPD943 Approved
0.7616 Intermediate Similarity NPD5406 Approved
0.7616 Intermediate Similarity NPD5404 Approved
0.7616 Intermediate Similarity NPD5405 Approved
0.7616 Intermediate Similarity NPD5408 Approved
0.7613 Intermediate Similarity NPD7390 Discontinued
0.7572 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7554 Intermediate Similarity NPD405 Clinical (unspecified phase)
0.7485 Intermediate Similarity NPD7473 Discontinued
0.7434 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7419 Intermediate Similarity NPD7003 Approved
0.7407 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7375 Intermediate Similarity NPD7458 Discontinued
0.7333 Intermediate Similarity NPD6663 Approved
0.732 Intermediate Similarity NPD3299 Clinical (unspecified phase)
0.7305 Intermediate Similarity NPD6232 Discontinued
0.7297 Intermediate Similarity NPD5736 Approved
0.7292 Intermediate Similarity NPD3023 Approved
0.7292 Intermediate Similarity NPD3026 Approved
0.7273 Intermediate Similarity NPD3024 Approved
0.7273 Intermediate Similarity NPD3025 Approved
0.7257 Intermediate Similarity NPD8150 Discontinued
0.7174 Intermediate Similarity NPD3022 Approved
0.7174 Intermediate Similarity NPD3021 Approved
0.7161 Intermediate Similarity NPD2935 Discontinued
0.7153 Intermediate Similarity NPD4196 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD6959 Discontinued
0.7134 Intermediate Similarity NPD1934 Approved
0.7123 Intermediate Similarity NPD3092 Approved
0.7118 Intermediate Similarity NPD6166 Phase 2
0.7118 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7118 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7115 Intermediate Similarity NPD2346 Discontinued
0.7097 Intermediate Similarity NPD2799 Discontinued
0.7091 Intermediate Similarity NPD2801 Approved
0.7083 Intermediate Similarity NPD3091 Approved
0.7067 Intermediate Similarity NPD9494 Approved
0.7048 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7047 Intermediate Similarity NPD3094 Phase 2
0.7047 Intermediate Similarity NPD1164 Approved
0.7029 Intermediate Similarity NPD5028 Approved
0.7029 Intermediate Similarity NPD4954 Approved
0.7029 Intermediate Similarity NPD5026 Approved
0.7029 Intermediate Similarity NPD5034 Approved
0.7029 Intermediate Similarity NPD4955 Approved
0.7029 Intermediate Similarity NPD36 Approved
0.7012 Intermediate Similarity NPD7028 Phase 2
0.7006 Intermediate Similarity NPD3882 Suspended
0.6989 Remote Similarity NPD8312 Approved
0.6989 Remote Similarity NPD8313 Approved
0.6988 Remote Similarity NPD7819 Suspended
0.6986 Remote Similarity NPD3412 Clinical (unspecified phase)
0.6975 Remote Similarity NPD6273 Approved
0.6971 Remote Similarity NPD5030 Phase 2
0.6957 Remote Similarity NPD1511 Approved
0.6954 Remote Similarity NPD7074 Phase 3
0.6951 Remote Similarity NPD3226 Approved
0.6948 Remote Similarity NPD3620 Phase 2
0.6948 Remote Similarity NPD3619 Clinical (unspecified phase)
0.6946 Remote Similarity NPD8438 Clinical (unspecified phase)
0.6923 Remote Similarity NPD5951 Approved
0.6909 Remote Similarity NPD4380 Phase 2
0.6897 Remote Similarity NPD7054 Approved
0.6887 Remote Similarity NPD2798 Approved
0.6882 Remote Similarity NPD5494 Approved
0.6875 Remote Similarity NPD5029 Approved
0.6875 Remote Similarity NPD5031 Approved
0.6875 Remote Similarity NPD5027 Approved
0.6872 Remote Similarity NPD5038 Approved
0.6872 Remote Similarity NPD5037 Approved
0.6871 Remote Similarity NPD7163 Clinical (unspecified phase)
0.6871 Remote Similarity NPD3095 Discontinued
0.6871 Remote Similarity NPD1512 Approved
0.6859 Remote Similarity NPD6651 Approved
0.6857 Remote Similarity NPD7472 Approved
0.6848 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6832 Remote Similarity NPD7910 Clinical (unspecified phase)
0.6818 Remote Similarity NPD3764 Approved
0.6816 Remote Similarity NPD5036 Approved
0.6813 Remote Similarity NPD5968 Phase 3
0.6813 Remote Similarity NPD7879 Clinical (unspecified phase)
0.681 Remote Similarity NPD2533 Approved
0.681 Remote Similarity NPD2534 Approved
0.681 Remote Similarity NPD2532 Approved
0.681 Remote Similarity NPD4378 Clinical (unspecified phase)
0.6805 Remote Similarity NPD4868 Clinical (unspecified phase)
0.6805 Remote Similarity NPD7768 Phase 2
0.68 Remote Similarity NPD5844 Phase 1
0.68 Remote Similarity NPD4379 Clinical (unspecified phase)
0.6798 Remote Similarity NPD3534 Clinical (unspecified phase)
0.6783 Remote Similarity NPD7635 Approved
0.678 Remote Similarity NPD7251 Discontinued
0.6772 Remote Similarity NPD1510 Phase 2
0.6765 Remote Similarity NPD7075 Discontinued
0.6761 Remote Similarity NPD4141 Clinical (unspecified phase)
0.6757 Remote Similarity NPD4059 Approved
0.6755 Remote Similarity NPD1283 Approved
0.6753 Remote Similarity NPD5952 Clinical (unspecified phase)
0.675 Remote Similarity NPD970 Clinical (unspecified phase)
0.6744 Remote Similarity NPD8127 Discontinued
0.6743 Remote Similarity NPD7228 Approved
0.6743 Remote Similarity NPD3818 Discontinued
0.6738 Remote Similarity NPD6831 Clinical (unspecified phase)
0.6736 Remote Similarity NPD4869 Clinical (unspecified phase)
0.6731 Remote Similarity NPD4060 Phase 1
0.6725 Remote Similarity NPD6234 Discontinued
0.6723 Remote Similarity NPD6797 Phase 2
0.6722 Remote Similarity NPD8055 Clinical (unspecified phase)
0.671 Remote Similarity NPD2313 Discontinued
0.6708 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6708 Remote Similarity NPD2800 Approved
0.6707 Remote Similarity NPD4160 Clinical (unspecified phase)
0.6707 Remote Similarity NPD7410 Clinical (unspecified phase)
0.6704 Remote Similarity NPD5035 Approved
0.6703 Remote Similarity NPD6836 Approved
0.6689 Remote Similarity NPD1651 Approved
0.6688 Remote Similarity NPD230 Phase 1
0.6687 Remote Similarity NPD2344 Approved
0.6686 Remote Similarity NPD7096 Clinical (unspecified phase)
0.6685 Remote Similarity NPD6559 Discontinued
0.6685 Remote Similarity NPD8434 Phase 2
0.6667 Remote Similarity NPD8032 Phase 2
0.6667 Remote Similarity NPD2342 Discontinued
0.6667 Remote Similarity NPD4628 Phase 3
0.6667 Remote Similarity NPD3750 Approved
0.6667 Remote Similarity NPD7411 Suspended
0.6648 Remote Similarity NPD7808 Phase 3
0.6647 Remote Similarity NPD3817 Phase 2
0.6646 Remote Similarity NPD1607 Approved
0.6645 Remote Similarity NPD7008 Discontinued
0.6644 Remote Similarity NPD4626 Approved
0.6629 Remote Similarity NPD7852 Clinical (unspecified phase)
0.6627 Remote Similarity NPD37 Approved
0.6626 Remote Similarity NPD6190 Approved
0.6624 Remote Similarity NPD1240 Approved
0.6623 Remote Similarity NPD3972 Approved
0.6623 Remote Similarity NPD4878 Approved
0.6623 Remote Similarity NPD9269 Phase 2
0.661 Remote Similarity NPD7804 Clinical (unspecified phase)
0.6607 Remote Similarity NPD6599 Discontinued
0.6599 Remote Similarity NPD9493 Approved
0.6588 Remote Similarity NPD1465 Phase 2
0.6585 Remote Similarity NPD7236 Approved
0.6584 Remote Similarity NPD1550 Clinical (unspecified phase)
0.6584 Remote Similarity NPD2343 Clinical (unspecified phase)
0.6584 Remote Similarity NPD1552 Clinical (unspecified phase)
0.6582 Remote Similarity NPD447 Suspended
0.6579 Remote Similarity NPD3600 Clinical (unspecified phase)
0.6564 Remote Similarity NPD4109 Clinical (unspecified phase)
0.6564 Remote Similarity NPD4110 Phase 3
0.6564 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6559 Remote Similarity NPD6534 Approved
0.6559 Remote Similarity NPD6535 Approved
0.6556 Remote Similarity NPD1281 Approved
0.6556 Remote Similarity NPD4338 Clinical (unspecified phase)
0.6556 Remote Similarity NPD5032 Approved
0.6554 Remote Similarity NPD7610 Discontinued
0.6548 Remote Similarity NPD3455 Phase 2
0.6543 Remote Similarity NPD1549 Phase 2
0.6543 Remote Similarity NPD7699 Phase 2
0.6543 Remote Similarity NPD7700 Phase 2
0.6536 Remote Similarity NPD7993 Clinical (unspecified phase)
0.6536 Remote Similarity NPD1876 Approved
0.6529 Remote Similarity NPD6801 Discontinued
0.6524 Remote Similarity NPD2309 Approved
0.6522 Remote Similarity NPD6099 Approved
0.6522 Remote Similarity NPD6100 Approved
0.6522 Remote Similarity NPD3020 Approved
0.6519 Remote Similarity NPD825 Approved
0.6519 Remote Similarity NPD2979 Phase 3
0.6519 Remote Similarity NPD826 Approved
0.6512 Remote Similarity NPD4967 Phase 2
0.6512 Remote Similarity NPD4966 Approved
0.6512 Remote Similarity NPD4965 Approved
0.651 Remote Similarity NPD8320 Phase 1
0.651 Remote Similarity NPD8319 Approved
0.6505 Remote Similarity NPD6213 Phase 3
0.6505 Remote Similarity NPD6214 Clinical (unspecified phase)
0.6505 Remote Similarity NPD6212 Phase 3
0.6503 Remote Similarity NPD74 Approved
0.6503 Remote Similarity NPD9266 Approved
0.6492 Remote Similarity NPD2491 Approved
0.6492 Remote Similarity NPD6823 Phase 2
0.6491 Remote Similarity NPD5760 Phase 2
0.6491 Remote Similarity NPD5761 Phase 2
0.6489 Remote Similarity NPD7282 Approved
0.6483 Remote Similarity NPD6124 Clinical (unspecified phase)
0.6481 Remote Similarity NPD7266 Discontinued
0.6478 Remote Similarity NPD6355 Discontinued
0.6478 Remote Similarity NPD5735 Approved
0.6474 Remote Similarity NPD4381 Clinical (unspecified phase)
0.6474 Remote Similarity NPD6779 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data